Javascript must be enabled to continue!
RNAi: VIRAL THERAPEUTICS
View through CrossRef
RNA interference or RNAi is a natural biological response in eukaryotic cells as their antiviral defense mechanisms. RNAi protects a range of
organisms by gene silencing or down regulating protein expression. RNAi induces the activation of ribonucleases targeting degradation of RNA
molecules encoding proteins. Genomic alterations have also been observed due to RNAi mechanisms. RNAi has been an important part of
biomedical research in terms of elimination and control of viral pathogens. Also RNAi intermediates as small interfering RNAs (siRNAs) are noted
to aid antiviral immunity. RNAi has also been involved in targeted transfer and activation of certain molecules which help in treatment of certain
clinical disorders. This technique has been used in many applications owed to its adaptabilities. RNAi is resilient over other techniques of gene
editing attributed to its dose-dependent applications providing the user a better control. The highly efcient results of RNAi have paved its way for
its application in viral infection diagnosis, control and treatment.
World Wide Journals
Title: RNAi: VIRAL THERAPEUTICS
Description:
RNA interference or RNAi is a natural biological response in eukaryotic cells as their antiviral defense mechanisms.
RNAi protects a range of
organisms by gene silencing or down regulating protein expression.
RNAi induces the activation of ribonucleases targeting degradation of RNA
molecules encoding proteins.
Genomic alterations have also been observed due to RNAi mechanisms.
RNAi has been an important part of
biomedical research in terms of elimination and control of viral pathogens.
Also RNAi intermediates as small interfering RNAs (siRNAs) are noted
to aid antiviral immunity.
RNAi has also been involved in targeted transfer and activation of certain molecules which help in treatment of certain
clinical disorders.
This technique has been used in many applications owed to its adaptabilities.
RNAi is resilient over other techniques of gene
editing attributed to its dose-dependent applications providing the user a better control.
The highly efcient results of RNAi have paved its way for
its application in viral infection diagnosis, control and treatment.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
e0157 RNA interference targeting ACE and AT1R gene reduced blood pressure and improved myocardial remodelling in SHR
e0157 RNA interference targeting ACE and AT1R gene reduced blood pressure and improved myocardial remodelling in SHR
Introduction
Angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) Type 1 receptor (ATlR) have been shown to play an important role in the pathogenesis ...
A non-canonical RNAi pathway controls virulence and genome stability in Mucorales
A non-canonical RNAi pathway controls virulence and genome stability in Mucorales
Abstract
Epimutations in fungal pathogens are emerging as novel phenomena that could explain the fast-developing resistance to antifungal drugs a...
Rôle de l'interférence à ARN (RNAi) dans l'intégrité du génome chez la levure S. pombe
Rôle de l'interférence à ARN (RNAi) dans l'intégrité du génome chez la levure S. pombe
Préserver l’intégrité du matériel génétique est crucial pour assurer la survie cellulaire et prévenir le développement tumoral. L’ARN à interférence (RNAi) joue un rôle important d...
Viral Hijacking of Host RNA-Binding Proteins: Implications for Viral Replication and Pathogenesis
Viral Hijacking of Host RNA-Binding Proteins: Implications for Viral Replication and Pathogenesis
In the intricate dance between viruses and host cells, RNA-binding proteins (RBPs) serve as crucial orchestrators of gene expression and cellular processes. We will delve into the ...

